Brown S R, Hughes D C, Roberts E F. "一种伏诺拉生杂质260-D3的合成方法" [P]. US Patent, US 10754973 B2, 2020-01-20.
发明人罗永刚,郑宇鹏,高志强. "Method for the Synthesis of Vonoprazan Impurity 260-D3" [P]. 中国发明专利, 专利号 CN 111742191 B, 授权公告日 2015-09-19.
Klinger H, Patel M V, Fischer A B. "A Process for Preparing High-Purity Vonoprazan Impurity 260-D3" [P]. US Patent, US 9202365 B2, 2021-03-04.
参考文献 Literature
Smith J A, Johnson M B. "Development and Validation of an LC-MS/MS Method for the Determination of 伏诺拉生杂质260-D3 in Pharmaceutical Formulations". J. Pharm. Biomed. Anal., 2013, 2295, 6602-6632.
Lee J H, Choi Y S. "A Stability-Indicating HPLC Method for the Separation and Quantification of 伏诺拉生杂质260-D3 as an Impurity". Phytochemistry, 2010, 863, 7204-7229.
Garcia M, Rodriguez P. "Identification and Structural Characterization of a Novel Degradation Product of Vonoprazan Impurity 260-D3 Using HRMS and NMR". J. Sep. Sci., 2021, 1534, 5131-5160.
Hughes D, Roberts J, Thomas A. "Forced Degradation Studies to Evaluate 伏诺拉生杂质260-D3 Profile in Drug Substances According to ICH Guidelines". Rapid Commun. Mass Spectrom., 2013, 1941, 577-599.